These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2863219)

  • 21. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].
    Canceil O; Limosin F; Passerieux C
    Encephale; 2009 Jan; Suppl 3():S101-7. PubMed ID: 19268178
    [No Abstract]   [Full Text] [Related]  

  • 22. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of Canadian psychiatry].
    Stip E
    Encephale; 2009 Jan; Suppl 3():S115-8. PubMed ID: 19268180
    [No Abstract]   [Full Text] [Related]  

  • 23. [5 years' experience with prolonged-action neuroleptics].
    Lopez-Ibor Aliño JM; Tabares Pujante J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(5):721-31. PubMed ID: 4150175
    [No Abstract]   [Full Text] [Related]  

  • 24. Eleven years of experience with depot neuroleptics.
    Gross H; Kaltenbäck E; Pfolz H
    Acta Psychiatr Belg; 1981; 81(2):128-32. PubMed ID: 6117183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risperidone injection. Deltoid muscle or buttocks?].
    Laberge L
    Perspect Infirm; 2010; 7(6):43-4. PubMed ID: 21141635
    [No Abstract]   [Full Text] [Related]  

  • 26. Risperidone long-acting injection in practice - more questions than answers?
    Taylor D
    Acta Psychiatr Scand; 2006 Jul; 114(1):1-2. PubMed ID: 16774654
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of two depot injection techniques.
    Mac Gabhann L
    Nurs Stand; 1998 Jun 3-9; 12(37):39-41. PubMed ID: 9732632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-acting risperidone-induced periorbital edema.
    Pelizza L
    J Clin Psychopharmacol; 2008 Dec; 28(6):709-10. PubMed ID: 19011446
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 31. Issues in the use of depot antipsychotics.
    Middlemiss MA; Beeber LS
    J Psychosoc Nurs Ment Health Serv; 1989 Jun; 27(6):36-7. PubMed ID: 2567781
    [No Abstract]   [Full Text] [Related]  

  • 32. New drug development in France and French-speaking countries. Short and long acting neuroleptics.
    Deniker P; Ginestet D; Peron-Magnan P
    Dis Nerv Syst; 1974 Jul; 35(7 Pt. 2):18-20. PubMed ID: 17894096
    [No Abstract]   [Full Text] [Related]  

  • 33. Leukopenia during therapy with risperidone long-acting injectable: two case reports.
    Uzun S; Kozumplik O; Jakovljević M; Folnegović-Smalc V
    J Clin Psychopharmacol; 2008 Dec; 28(6):713-4. PubMed ID: 19011449
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug levels after withdrawal of long-term depot neuroleptics.
    Amdisen A; Thomsen NJ
    Lancet; 1981 Jun; 1(8235):1425. PubMed ID: 6113382
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmaceutical characteristics of depot neuroleptics. Their use and efficacy in the psychiatric clinic].
    Mungiu OC; Chiriţă V; Boişteanu P; Mungiu A; Cosmovici N; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):43-7. PubMed ID: 2899341
    [No Abstract]   [Full Text] [Related]  

  • 36. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
    Möller HJ; Kissling W
    Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
    [No Abstract]   [Full Text] [Related]  

  • 37. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antipsychotic drugs with long lasting effect. Depot neuroleptics].
    Kristjansen P
    Ugeskr Laeger; 1980 Mar; 142(10):657-60. PubMed ID: 6102811
    [No Abstract]   [Full Text] [Related]  

  • 39. [Retrospective comparative study of treatment with delayed-action neuroleptics and neuroleptics administrated orally in long-term psychosis].
    Chambon O; Marie-Cardine M; Terra JL; Corot P
    Encephale; 1988; 14(4):293-7. PubMed ID: 2904356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cost analysis of the strategies in the treatment of schizophrenics: the place of sustained release injectable atypical antipsychotics].
    Gasquet I; Bouhassira M; Launois R
    Encephale; 2005; 31(4 Pt 1):517-8. PubMed ID: 16389719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.